These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 12677783)
21. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Verucchi G; Calza L; Manfredi R; Chiodo F Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741 [TBL] [Abstract][Full Text] [Related]
22. [HCV / HIV co-infection: a different perspective]. Jmelnitzky AC Acta Gastroenterol Latinoam; 2002 May; 32(1):7-10. PubMed ID: 12136694 [TBL] [Abstract][Full Text] [Related]
23. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database. Petoumenos K; Ringland C; HIV Med; 2005 May; 6(3):155-63. PubMed ID: 15876281 [TBL] [Abstract][Full Text] [Related]
24. Dark skies challenge management of hepatic disorders in patients with HIV disease. MacDougall DS J Int Assoc Physicians AIDS Care; 1999 Feb; 5(2):24-31. PubMed ID: 11366254 [TBL] [Abstract][Full Text] [Related]
25. [Influence of anitiretroviral therapy on bone tissue metabolism in patients with HIV]. Olczak A; Pawłowska M; Drózdz W Przegl Epidemiol; 2008; 62(1):155-62. PubMed ID: 18536239 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic interventions for HIV infection and chronic viral hepatitis. Cooper CL Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617 [TBL] [Abstract][Full Text] [Related]
27. [HIV-HBV-coinfection--diagnosis and therapy]. Koch S; Göbels K; Oette M; Heintges T; Erhardt A; Häussinger D Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1873-7. PubMed ID: 16915550 [No Abstract] [Full Text] [Related]
28. Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review. Robertson SM; Scarsi KK; Postelnick MJ; Lynch P Pharmacotherapy; 2005 Aug; 25(8):1068-72. PubMed ID: 16207097 [TBL] [Abstract][Full Text] [Related]
29. Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. Torti C; Lapadula G; Uccelli MC; Quiros-Roldan E; Regazzi M; Ladisa N; Micheli V; Orani A; Patroni A; Caputo SL; Tirelli V; Di Giambenedetto S; Cologni G; Costarelli S; Gargiulo F; Manca N; Carosi G; Int J Antimicrob Agents; 2007 Feb; 29(2):185-90. PubMed ID: 17011754 [TBL] [Abstract][Full Text] [Related]
30. Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection. Dervisevic S; Pillay D J HIV Ther; 2003 Nov; 8(4):89-95. PubMed ID: 14671506 [TBL] [Abstract][Full Text] [Related]
32. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821 [TBL] [Abstract][Full Text] [Related]
33. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection]. Bani-Sadr F Gastroenterol Clin Biol; 2003 May; 27(5):528-33. PubMed ID: 12843917 [No Abstract] [Full Text] [Related]
35. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy? Cicconi P; Cozzi-Lepri A; Phillips A; Puoti M; Antonucci G; Manconi PE; Tositti G; Colangeli V; Lichtner M; Monforte Ad; AIDS; 2007 Mar; 21(5):599-606. PubMed ID: 17314522 [TBL] [Abstract][Full Text] [Related]
36. Managing issues related to antiretroviral therapy. Lesho EP; Gey DC Am Fam Physician; 2003 Aug; 68(4):675-86. PubMed ID: 12952384 [TBL] [Abstract][Full Text] [Related]
37. Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy. Chauvel O; Lacombe K; Bonnard P; Lascoux-Combe C; Molina JM; Miailhes P; Girard PM; Carrat F Antivir Ther; 2007; 12(7):1115-26. PubMed ID: 18018770 [TBL] [Abstract][Full Text] [Related]
38. Interaction between HIV-1 and HCV infections: towards a new entity? Winnock M; Salmon-Céron D; Dabis F; Chêne G J Antimicrob Chemother; 2004 Jun; 53(6):936-46. PubMed ID: 15117928 [TBL] [Abstract][Full Text] [Related]
39. The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug? Puoti M; Cozzi-Lepri A; Ancarani F; Bruno R; Ambu S; Ferraro T; Tundo P; Santantonio T; Toti M; Bonasso M; d'Arminio Monforte A; ; Antivir Ther; 2004 Oct; 9(5):811-7. PubMed ID: 15535419 [TBL] [Abstract][Full Text] [Related]